- Home
- REPL vs GDEN Comparison
REPL vs GDEN Comparison
Compare REPL & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- GDEN
- Stock Information
- Founded
- REPL 2015
- GDEN 1998
- Country
- REPL United States
- GDEN United States
- Employees
- REPL N/A
- GDEN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- GDEN Services-Misc. Amusement & Recreation
- Sector
- REPL Health Care
- GDEN Consumer Discretionary
- Exchange
- REPL Nasdaq
- GDEN Nasdaq
- Market Cap
- REPL 547.0M
- GDEN 642.7M
- IPO Year
- REPL 2018
- GDEN 1999
- Fundamental
- Price
- REPL $9.42
- GDEN $29.49
- Analyst Decision
- REPL Buy
- GDEN Hold
- Analyst Count
- REPL 9
- GDEN 6
- Target Price
- REPL $12.00
- GDEN $32.20
- AVG Volume (30 Days)
- REPL 2.6M
- GDEN 650.1K
- Earning Date
- REPL 11-06-2025
- GDEN 11-06-2025
- Dividend Yield
- REPL N/A
- GDEN 3.48%
- EPS Growth
- REPL N/A
- GDEN N/A
- EPS
- REPL N/A
- GDEN 0.20
- Revenue
- REPL N/A
- GDEN $643,485,000.00
- Revenue This Year
- REPL N/A
- GDEN N/A
- Revenue Next Year
- REPL N/A
- GDEN $2.15
- P/E Ratio
- REPL N/A
- GDEN $144.92
- Revenue Growth
- REPL N/A
- GDEN N/A
- 52 Week Low
- REPL $2.68
- GDEN $19.57
- 52 Week High
- REPL $17.00
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- REPL 62.38
- GDEN 69.01
- Support Level
- REPL $8.50
- GDEN $28.73
- Resistance Level
- REPL $9.30
- GDEN $30.20
- Average True Range (ATR)
- REPL 0.61
- GDEN 0.92
- MACD
- REPL -0.14
- GDEN 0.26
- Stochastic Oscillator
- REPL 75.95
- GDEN 93.27
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.